Choose a language and wait for the translated text.
US District Judge Zahid Quraishi in Trenton, New Jersey, said Novo Nordisk did not deserve a preliminary injunction, having failed to show that Eli Lilly's ads threatened sales, undermined its goodwill, or caused lasting damage to its clinical reputation.
US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk | PharmaVoice
